Arnold J. Levine

Arnold J. Levine (board member) discloses dealings in 5 companies, chiefly Applera Corp, Invitrogen Corp and Innoviva, Inc. In total, 57 filings cover trades dated from 1 March 2006 to 22 September 2021.

On the market, this insider has only sold: 11 sales, €1.1M in total. Outside the open market, there are 28 share grants and 11 option exercises. Since January 2021: no purchases and 7 sales on the market.

The latest filing, published on 23 September 2021, reports an open-market sale of €90k in PMV Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.